EGFR S492R
|
CRC
|
EGFR S492R
|
CRC
|
Sym004 Sensitive: C4 – Case Studies
|
Sym004 Sensitive: C4 – Case Studies
|
EGFR S492R
|
CRC
|
EGFR S492R
|
CRC
|
panitumumab Sensitive: C4 – Case Studies
|
panitumumab Sensitive: C4 – Case Studies
|
EGFR S492R
|
CRC
|
EGFR S492R
|
CRC
|
cetuximab Resistant: C4 – Case Studies
|
cetuximab Resistant: C4 – Case Studies
|
EGFR S492R
|
CRC
|
EGFR S492R
|
CRC
|
cetuximab + panitumumab Resistant: D – Preclinical
|
cetuximab + panitumumab Resistant: D – Preclinical
|